Amyotrophic lateral sclerosis (ALS). What is amyotrophic lateral sclerosis? It is a progressive neurological disease that affects the control of muscle.

Slides:



Advertisements
Similar presentations
Amyotrophic Lateral Sclerosis (ALS)
Advertisements

MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
ALS Research Yesterday, Today and Tomorrow Heather D. Durham, PhD.
Crystallization and Dimer Exchange of the Protein Superoxide Dismutase Emily Clark Dr. Joe Beckman Department of Biochemistry/ Biophysics Oregon State.
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (Lou Gehrig’s Disease)
Motor neuron disease What are motor neuron diseases? Who is at risk? What are the causes motor neuron diseases? How are they classified? What are the symptoms.
Persons with Neurological Defects Special Needs. Bells Palsy Facial nerve paralysis Damage to the facial nerve may cause imbalance of the face at rest.
Comparing the Toxicity of Zinc Deficient Superoxide Dismutase (SOD) and the Quad SOD mutant: Implications for Amyotrophic Lateral Sclerosis Jesse Fitzpatrick.
An Investigation of the Interactions Between Zinc-deficient and Copper, Zinc Superoxide Dismutase Katie Meyers Dr. Joe Beckman Department of Biochemistry/Biophysics.
Motor Neurone Disease Different types & Life Expectancy
Zinc-deficient SOD in ALS Emily Clark Dr. Joe Beckman Department of Biochemistry/Biophysics.
Amyotrophic Lateral Sclerosis (ALS)
ALS Kate Crain. Amyotrophic Lateral Sclerosis Lou Gehrig Disease Charcot’s Syndrome.
Copper Binding of Mutant Quad SOD1
Investigation of mutated Cu/Zn Superoxide Dismutase Sam Schuberg Beckman Laboratory Howard Hughes Medical Institute: Summer 2007.
An Investigation into Zinc Transporter Expression in an Animal Model of Amyotrophic Lateral Sclerosis By Thomas Lew Mentor: Dr. Joe Beckman Linus Pauling.
Natalie Biggs Mentor: Dr. Joseph Beckman
Part I Mr. Robert Middelton … Over the past few years, he noticed...a slowly developing weakness initially in his hands and arms, now spreading to his.
Amyotrophic Lateral Sclerosis (ALS) Sarah Belair and Hannah McLaughlin.
The Nervous System. Types Central Nervous System (CNS)Peripheral Nervous System (PNS)
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
What is Huntington’s disease? It is a progressive degeneration of the nerve cells in the brain. This disease cause uncontrolled movements, emotional problems,
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Wanted. Lou gehrig’s diease  Lou gehrig diease is a diease of the nerve cells in the brain and spinal cord that control voluntary muscle movement.
Lou Gehrig's Disease By: Brittany Harden.
By Intracerebroventricular Delivery of VEGF in a Rat Model of ALSEGF in a Rat Model of ALS Treatment of Motoneuron Degeneration.
PATRICK CASEY FALL 2007 PARAMEDIC CLASS Amyotrophic Lateral Sclerosis.
Amyotrophic Lateral Sclerosis and Superoxide Dimutase 1 (SOD1) Iasson Yi CHEM 4700.
Oxidative Stress By: Andrew Lorusso. Overview Alvaro Estevez an associate professor at the University of Central Florida led a multi-university team that.
Health Presentation Amyotrophic Lateral Sclerosis Zhenette Stevens.
LOU GEHRIG’S DISEASE.  Also known as Amyotrophic Lateral Sclerosis  Is a disease of the nerve cells in the brain and spinal cord that control voluntary.
Lou Gehrig’s Disease. - Jean-Martin Charcot discovered Men most affected - Still remains mostly a mystery.
Amyotrophic Lateral Sclerosis (ALS)
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
Name of Gene USH1C DNA Sequence 50,522 Name of Protein LMNA la min A/C [ Homo sapiens ( human) ] Amino Acid Sequence 533aa Condition/Disease Protein makes.
ALS by Cheetahs.  Güldeniz Karakuş  Abide Yıldız  Zeynep Özal  Esra Akman.
漸凍症 amyotrophic lateral sclerosis. Lou Gehrig's disease 1939 Jean-Martin Charcot Amyotrophic lateral sclerosis (ALS) (Rosen DR et al. Nature 1993) 1869.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Patient #5 ALS. Patient Background and Problems Patient #5- Andrew, a 45 year-old single father of two, comes to you in confidence. He’s noticed that.
By TJ Wittmer Muscle weakness. Slurred speech. Also it is very difficult swallow.
ALS: Amyotrophic Lateral Sclerosis Lou Gehrig’s Disease.
Neurological Disorders
The Neurochemistry of Friedreich’s Ataxia By: Michelle Donnelly, Virginia Gamero, Vinson Li, and Pooja Maharajh PHM142 Fall 2015 Coordinator: Dr. Jeffrey.
PATIENT #5: ANDREW Ashton Crowe Rayvin Ewers Miranda McCormick.
Amyotrophic Lateral Sclerosis (ALS)
ALS Samuel Awad & Osama Jamali. Introduction ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds.
Superoxide Dismutase and Amyotrophic Lateral Sclerosis
Charcot-Marie- Tooth Disease Jessica Tzeng. History  Named after Jean-Martin Charcot, Pierre Marie (Charcot’s pupil), and Howard Henry Tooth  Not a.
Amyotrophic Lateral Sclerosis
Stephen Hawking. Biography Stephen William Hawking was born on 8 January In Oxford, England. Stephen then went on to Cambridge to do research in.
Brain injuries. Concussion Slight brain injury Slight brain injury NO permanent damage NO permanent damage Symptoms: Symptoms: Dizziness Dizziness “seeing.
ALS or Lou Gehrig’s disease By: Nathaniel Baughman.
By: Roman Amyotrophic Lateral Sclerosis (ALS) is also known as Lou Gehrig's disease.
Amyotrophic Lateral Sclerosis (ALS). Also know as Lou Gehrig's Disease Named after the New York Yankees baseball star who played first base and was diagnosed.
ZOO405 by Rania Baleela is licensed under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 Unported LicenseRania BaleelaCreative Commons Attribution-
Amyotrophic lateral sclerosis
Mondays with Andrew Tara and Annie. Andrew’s Story Andrew, a 45 year-old single father of two, comes to you in confidence. He’s noticed that the muscles.
Amyotrophic Lateral Sclerosis (ALS)
Activity Communication Breakdown
Ashton Crowe Rayvin Ewers Miranda McCormick
Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS)
What does this protein make up or do? amyotrophic lateral sclerosis
Assessing the role of the ALS-associated gene NEK1 in zebrafish motor neuron development Amy Stark.
ALS: Amyotrophic lateral sclerosis
Ashton Crowe Rayvin Ewers Miranda McCormick
What does this protein make up or do? ALS or Lou Gehrig’ Disease
Nervous System Part 2.
By Ivy Stites and Keya Patel
Presentation transcript:

Amyotrophic lateral sclerosis (ALS)

What is amyotrophic lateral sclerosis? It is a progressive neurological disease that affects the control of muscle movement due to its damaging affects on motor neurons in the spinal cord and the brain It is a progressive neurological disease that affects the control of muscle movement due to its damaging affects on motor neurons in the spinal cord and the brain Picture from the Memory & Aging Center

Significance of the Name of this Disease A-myo-trophic comes from Greek A-myo-trophic comes from Greek “A” = no/negative “A” = no/negative “myo” = muscle “myo” = muscle “trophic” = nourishment “trophic” = nourishment “No Muscle Nourishment” “No Muscle Nourishment” Lateral = defines location of the nerve cells that signal and control the muscles Lateral = defines location of the nerve cells that signal and control the muscles Sclerosis = scarring and hardening in the degenerating region Sclerosis = scarring and hardening in the degenerating region From

Other common names for this disease: Motor neuron disease Motor neuron disease Charcot’s disease Charcot’s disease Lou Gehrig’s disease Lou Gehrig’s disease Picture from the Neuromuscular website

Who was Lou Gehrig? Lou Gehrig was a baseball player for the New York Yankees in the late 1920s and 1930s Lou Gehrig was a baseball player for the New York Yankees in the late 1920s and 1930s Picture from lougehrig.com

What genes are related to ALS? Copper/zinc Superoxide dismutase 1 (SOD1) Copper/zinc Superoxide dismutase 1 (SOD1) Heavy neurofilament subunit (NEFH) Heavy neurofilament subunit (NEFH) Peripherin (PRPH) Peripherin (PRPH) Dynactin (DCTN1) Dynactin (DCTN1)

This disease affects SOD1 gene on chromosome 21 Mutations occurs at the SOD1 located on the long arm of Chromosome 21

Cu/Zn Superoxide dismutase 1 gene Codes for the protein Cu/Zn Superoxide dismutase 1 Codes for the protein Cu/Zn Superoxide dismutase 1 Contains 5 exons and 4 introns Contains 5 exons and 4 introns mRNA is 981 base pairs long mRNA is 981 base pairs long

Structure of SOD1 Protein

SOD1 protein SOD1 protein Removes dangerous superoxide radicals by converting them to non-harmful substances Removes dangerous superoxide radicals by converting them to non-harmful substances O2 ̄ + O2 ̄ + 2H+ → O2 + H2O2 Protein contains 154 amino acids Protein contains 154 amino acids Has one domain, SOD_Cu Has one domain, SOD_Cu

Mutations in SOD1 protein Several different mutations in this enzyme may all result in ALS, making the exact molecular cause of the disease difficult to ascertain Several different mutations in this enzyme may all result in ALS, making the exact molecular cause of the disease difficult to ascertain

Mutations in SOD1 protein continued... Some mutations in SOD1 associated with ALS: Some mutations in SOD1 associated with ALS: –R4V –G93A –G37R –G16S

Picture from The ALS Society of Canada

Nature and Characteristics of ALS Forms: Forms: –Two types of ALS: Sporadic – no family history Sporadic – no family history Familial – family history/background Familial – family history/background –90% of the known cases are sporadic

ALS continued... Types of Familial Types of Familial –Autosomal dominant –Autosomal recessive –X-linked dominant Sporadic Sporadic

Who Gets ALS? “According to the ALS CARE Database, 60% of the people with ALS in the database are men and 93% of patients in the database are caucasian.” “According to the ALS CARE Database, 60% of the people with ALS in the database are men and 93% of patients in the database are caucasian.” Normally occurs in people between 40 to 70 years of age Normally occurs in people between 40 to 70 years of age –Also can occur in people in their 20’s and 30’s From The ALS Association

Cause of ALS Due to a mutation in SOD1, the superoxide radicals are not neutralized Due to a mutation in SOD1, the superoxide radicals are not neutralized The radicals attack the motor neurons and degrade them The radicals attack the motor neurons and degrade them Muscles are not able to be stimulated Muscles are not able to be stimulated

Symptoms of ALS First signs and symptoms (frequently overlooked) First signs and symptoms (frequently overlooked) –Twitching and cramping of muscles (especially in hands and feet) –Stiffness –Weakness (especially in hands, arms and legs) –Slurred speech Picture taken from the National Institute of Aging

Symptoms continued... Later signs and symptoms: –D–D–D–Difficulty chewing and swallowing –S–S–S–Shortness of breath –M–M–M–Muscle weakness due to wasting away of muscles Causes muscles to become smaller –R–R–R–Respiratory failure –P–P–P–Paralysis Picture from the ALS Association

This picture from the Neuromuscular website shows the wasting away of a person’s hands and arms This picture from the Neuromuscular website shows the wasting away of a person’s hands and arms

Symptoms, or patterns of symptoms, are not the same for each ALS individual Symptoms, or patterns of symptoms, are not the same for each ALS individual However, progressive muscle weakness and paralysis are universally experienced However, progressive muscle weakness and paralysis are universally experienced Since ALS attacks only motor neurons, the sense of sight, touch, hearing, taste, and smell are not affected Since ALS attacks only motor neurons, the sense of sight, touch, hearing, taste, and smell are not affected Patients usually only live 3 to 5 years after they are diagnosed Patients usually only live 3 to 5 years after they are diagnosed There are some cases; however, where individuals have lived 10 or more years There are some cases; however, where individuals have lived 10 or more years

Diagnosing ALS 5,600 people in the US are diagnosed with ALS each year 5,600 people in the US are diagnosed with ALS each year ALS is a very difficult disease to diagnose ALS is a very difficult disease to diagnose Blood tests, Urine tests, Spinal taps, x-rays, muscle or nerve biopsies, or a neurological examinations are administered Blood tests, Urine tests, Spinal taps, x-rays, muscle or nerve biopsies, or a neurological examinations are administered Picture from coolrunning.com

Medication for ALS Rilutek (brand name) / riluzole (generic) – slows progression of ALS Rilutek (brand name) / riluzole (generic) – slows progression of ALS –It is the only prescription drug for ALS –Approved in December 1995 From the MDA Publications Picture from healthlit.org

Hypothesis The mechanisms that cause mutations in SOD1 that lead to ALS are unknown The mechanisms that cause mutations in SOD1 that lead to ALS are unknown

Hypothesis #1 An increase or a decrease in the activity of SOD1 may cause ALS An increase or a decrease in the activity of SOD1 may cause ALS –We theorized that a decrease, rather than an increase, may be the cause of ALS. –Theory: decrease = produces more harmful free radicals –We searched NCBI in support for both an increase and a decrease in SOD1 activity

Support from NCBI One study conducted by Rosen found that increased levels of expression of SOD1 in mice would produce excessive levels of hydrogen peroxide One study conducted by Rosen found that increased levels of expression of SOD1 in mice would produce excessive levels of hydrogen peroxide From OMIM

Picture from The ALS Society of Canada

Support continued... According to Kunst over-expression of normal SOD1 accelerates disease onset and progression According to Kunst over-expression of normal SOD1 accelerates disease onset and progression –However, a decrease or increase in SOD1 activity is not sufficient to cause ALS in mice From PubMed

Hypothesis #2 SOD1 may lose its ability to bind zinc (Zn), Copper (Cu), or both SOD1 may lose its ability to bind zinc (Zn), Copper (Cu), or both –This may cause SOD1 to lose its ability to process free radicals

From MDA Publications

Support from NCBI Zinc and Copper = normal Zinc and Copper = normal Zinc removed = toxic Zinc removed = toxic Zinc and Copper removed = non-toxic Zinc and Copper removed = non-toxic Copper removed = not studied yet Copper removed = not studied yet Zinc that is bound to SOD1 may stabilize the protein Zinc that is bound to SOD1 may stabilize the protein From PubMed

Support continued... Zinc-deficient SOD1 produces more free radicals than it destroys Zinc-deficient SOD1 produces more free radicals than it destroys SOD1 mutant can not bind zinc as strongly as normal SOD1 SOD1 mutant can not bind zinc as strongly as normal SOD1

Credits NCBI NCBI ALS Organization ALS Organization National Institute of Aging The ALS Association The ALS Society of Canada MDA Publications MDA Publications Memory & Aging Center Memory & Aging Center Neuromuscular website Neuromuscular website lougehrig.com lougehrig.com coolrunning.com coolrunning.com healthlit.org healthlit.org